Schedule of Stock Option Activity (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Share-based Payment Arrangement [Abstract] | ||
| Options outstanding, beginning balance | 152,806 | 176,962 |
| Weighted average exercise price, beginning balance | $ 18.11 | $ 17.93 |
| Options, forfeited | (4,310) | (24,156) |
| Weighted average exercise price, forfeited | $ 16.80 | $ 16.80 |
| Options, granted | 30,000 | |
| Weighted average exercise price, granted | $ 11.70 | |
| Weighted average remaining contractual term, Options granted | 1 year 2 months 12 days | |
| Options outstanding, ending balance | 178,496 | 152,806 |
| Weighted average exercise price, ending balance | $ 17.07 | $ 18.11 |
| Weighted average remaining contractual term, ending | 3 years 7 months 6 days | |
| Options, exercisable | 154,398 | |
| Weighted average exercise price, exercisable | $ 17.14 | |
| Weighted average remaining contractual term, exercisable | 3 years 7 months 6 days | |
| X | ||||||||||
- Definition Number of resticted stock grants in period weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|